Safety and Tolerability Study of SHP626 in Overweight and Obese Adults

Clinical trial NCT02287779 · COMPLETED

Trial details

NCT number: NCT02287779
Sponsor: Mirum Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Alcoholic Steatohepatitis

Start date: 2015-01-19
Primary completion: 2015-06-19
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.